ライフサイエンスコーパス: health-related quality of life

1 diotherapy; performance status; and previous health-related quality of life).

2 icantly predicted future hospitalization and health-related quality of life.

3 verse events, gastrointestinal symptoms, and health-related quality of life.

4 faction with melanoma care, unmet needs, and health-related quality of life.

5 ] patients excluded), 4,529 provided data on health-related quality of life.

6 s, comparable to previous reports of overall health-related quality of life.

7 ovement, satisfaction with intervention, and health-related quality of life.

8 ing tooth surfaces were associated with oral health-related quality of life.

9 Vitiligo has a major impact on health-related quality of life.

10 n-group difference in quadriceps strength or health-related quality of life.

11 y criteria, and 570 (86%) were evaluable for health-related quality of life.

12 ompanied by any significant deterioration in health-related quality of life.

13 rvive, studying their nutritional status and health-related quality of life.

14 lnutrition, together with a decline in their health-related quality of life.

15 or did it improve overall sexual function or health-related quality of life.

16 s in the carfilzomib group reported superior health-related quality of life.

17 ondary outcomes included sexual function and health-related quality of life.

18 ted in increased survivorship and a focus on health-related quality of life.

19 persist and what direct impact they have on health-related quality of life.

20 on early (30 days) or medium term (6 months) health-related quality of life.

21 explore the association between frailty and health-related quality of life.

22 an important target for enhancement of oral health-related quality of life.

23 common psychiatric disorder affecting their health-related quality of life.

24 ve motor performance and a greater impact on health-related quality of life.

25 between the lung clearance index or FEV1 and health-related quality of life.

26 atment efficacy, patient and payer cost, and health-related quality of life.

27 relationship between depressive symptoms and health-related quality of life.

28 ate in reducing symptom burden and promoting health-related quality of life.

29 e symptoms are strongly associated with poor health-related quality of life.

30 which contributes to inferior self-reported health-related quality of life.

31 organ failure, adverse events, survival, and health-related quality of life.

32 s, impaired physical function, and decreased health-related quality of life.

33 time, eye movements, and vision-related and health-related quality of life.

34 apy may experience a deterioration in mental health-related quality of life.

35 on a 0- to 100-point scale indicating better health-related quality of life.

36 on with infliximab to assess how they affect health-related quality of life.

37 ; and the effect of screening on anxiety and health-related quality of life.

38 ke and pacemaker implantation) and had worse health-related quality of life.

39 ted with increased pain and reduced physical health-related quality of life.

40 ital functioning, psychological distress, or health-related quality of life.

41 en, and pain response; pharmacokinetics; and health-related quality of life.

42 ng of cardiac function, cardiac symptoms, or health-related quality of life.

43 circulating biomarkers, functional class, or health-related quality of life.

44 (0.07 units; 95% CI, -0.02 to 0.16) or child health-related quality of life (0.89 units; 95% CI, -0.5

45 roup, reported improvements in their child's health-related quality of life (1.53 units; 95% CI, 0.51

46 8), and 10.73 (8.04-14.33); poor respiratory health-related quality of life-1.49 (1.28-1.75), 2.69 (2

47 ality or morbidity (4 trials [n = 51356]) or health-related quality of life (10 trials [n = 52423]).

48 Physical activity levels (health-related quality of life [36-item short-form healt

49 arious and missing tooth surfaces), and oral health-related quality of life (38 y).

50 ared with usual care, did not improve mental health-related quality of life 6 months after ICU discha

51 Good outcome indicated health-related quality of life about 1.5 SD below the U.

52 ate, hospital admissions, exacerbations, and health-related quality of life across all BSI risk strat

53 ) stay as well as 6-month post-ICU discharge health-related quality of life, activities of daily livi

54 Integrating differential patient-reported health-related quality of life adjustments for patients

55 Primary end point was health-related quality of life after 1 year, assessed wi

56 traumatic stress disorder and depression and health-related quality of life after cardiac surgery and

57 To compare health-related quality of life among intermediate-risk p

58 he association between frailty and long-term health-related quality of life among survivors of critic

59 had positive effects on self-reported mental health related quality of life and psychosocial wellbein

60 on and post-traumatic stress symptomatology, health-related quality of life and costs.

61 tions of medical and surgical care, anxiety, health-related quality of life and dependence level on b

62 ransplant outcomes, associated with anxiety, health-related quality of life and dependence.

63 s of the impact of serious adverse events on health-related quality of life and hospital care costs.

64 An invasive treatment strategy improves health-related quality of life and intermittent claudica

65 care that improves patient outcomes such as health-related quality of life and is consistent with th

66 ovigilance database; we derived estimates of health-related quality of life and mortality from the sc

67 risks of morbidity, cognitive decline, poor health-related quality of life and mortality, and higher

68 Health-related quality of life and neurocognitive functi

69 tive function (will be reported separately), health-related quality of life and neurological function

70 lack of data relating to cost-effectiveness, health-related quality of life and patient and clinician

71 ssociated with dose-dependent improvement in health-related quality of life and patient preferences f

72 Only the previous health-related quality of life and performance status we

73 sepsis face long-term sequelae that diminish health-related quality of life and result in increased c

74 more detail including studies that measured health-related quality of life and studies that investig

75 be associated with a considerable decline in health-related quality of life and yet still a poor prog

76 Communication, health-related quality-of-life and satisfaction measures

77 , vitamin status, gastrointestinal symptoms, health-related quality of life, and adverse events.

78 ciations between small fiber deficits, pain, health-related quality of life, and clinical data.

79 physical activity, self-reported measures of health-related quality of life, and clinician reported g

80 istributions, treatment efficacy, mortality, health-related quality of life, and direct medical expen

81 ed with significant morbidity, impairment to health-related quality of life, and economic costs to so

82 Physical activity measures (accelerometry, health-related quality of life, and frailty) demonstrate

83 ect to lung function and respiratory health, health-related quality of life, and functional status, a

84 sical fitness, minimizing fatigue, enhancing health-related quality of life, and optimizing chemother

85 ry outcome measures were functional outcome, health-related quality of life, and patient satisfaction

86 Long-term survival, health-related quality of life, and quality-adjusted lif

87 ody weight (BW) and composition, adipokines, health-related quality of life, and safety data before a

88 capture the full impact of multimorbidity on health-related quality of life, and that the MWI is feas

89 improve motor function, motor fluctuations, health-related quality of life, and to reduce medication

90 nd spine-specific limitations in activities, health-related quality of life, anxiety and depression,

91 , objective measures of cardiac function and health-related quality of life are lacking in long-term

92 Secondary outcomes were: participant health related quality of life as measured by the Minnes

93 Survival status and health-related quality of life as assessed using the Sho

94 This analysis focuses on 2-year toxicity and health-related quality of life as secondary endpoints; a

95 The primary outcome measure was health-related quality of life, as assessed by the physi

96 interventions improved child BMI z score and health-related quality of life, as well as parental reso

97 For PROs, we used health-related quality of life assessed by the Health an

98 Secondary outcomes were health-related quality of life (assessed by Parkinson Di

99 Health-related quality of life assessments reliably dist

100 ial blood gas parameters, clinical symptoms, health-related quality-of-life assessments, polysomnogra

101 However, some health-related quality-of-life assessments, the spiromet

102 ymptoms, lower sexual activity, and inferior health-related quality of life at 3-year follow-up (P <

103 The health-related quality of life before ICU admission; at

104 The primary outcome was change in mental health-related quality of life between ICU discharge and

105 id not have additional beneficial effects on health-related quality of life beyond those with shorter

106 ent- and family-centered care that optimizes health-related quality of life by anticipating, preventi

107 Child oral health-related quality of life (COHRQoL) has been increa

108 int and other types of bleeding and improves health-related quality of life compared with on-demand b

109 t nonmedical costs, productivity losses, and health-related quality-of-life data during the intervent

110 Secondary outcomes included health-related quality of life, depression, anxiety, and

111 Health-related quality of life did not differ between gr

112 The number of adverse events and changes in health-related quality of life did not differ between th

113 exual function scores, partner intimacy, and health-related quality of life did not differ significan

114 Social functioning or health-related quality of life did not differ significan

115 d the area under the curve between different health-related quality of life domains.

116 microinfarction and measure their effect on health-related quality of life during 6 months after TAV

117 performance status were associated with the health-related quality of life during the 18-month follo

118 patient-reported outcomes (PROs), including health-related quality of life, during treatment with ne

119 -proBNP)concentrations, Borg dyspnoea score, health-related quality of life (EQ-5D score), survival,

120 Food allergy health-related quality of life (FAQOL) has been shown to

121 disorder, burden, activity restriction, and health-related quality of life) for informal caregivers

122 al illness experienced greater impairment in health-related quality of life, functional dependence, a

123 thma and rhinitis symptoms, disease-specific health-related quality of life, generic quality of life

124 l and gastric cancer have increased focus on health-related quality of life (HR-QL) in survivorship.

125 ersus lenalidomide and dexamethasone (Rd) on health-related quality of life (HR-QoL) in the Carfilzom

126 The primary outcome was change in health-related quality of life (HRQL) at 6 months compar

127 tion fraction patients have equally impaired health-related quality of life (HRQL) compared with thos

128 th of stay, decrease opioid use, and improve health-related quality of life (HRQL) for pediatric pati

129 This study evaluated the effect of PTG on health-related quality of life (HRQL) in asymptomatic in

130 he aim of this study was to assess long-term health-related quality of life (HRQL) in patients after

131 tion-level study was conducted to define the health-related quality of life (HRQL) of individuals liv

132 Despite the importance of health-related quality of life (HRQL) outcomes among pat

133 and reduced ejection fraction have impaired health-related quality of life (HRQL) with variable resp

134 imary outcome); mean risk factor reductions, health-related quality of life (HRQL), and treatment sat

135 ations with various costs and impairments to health-related quality of life (HRQL).

136 Evaluations included tumor response and health-related quality of life (HRQL).

137 erventions for, IgE-mediated food allergy on health-related quality of life (HRQL).

138 This study evaluated the impact of PPOIT on health-related quality of life (HRQL).

139 capacity (6-min walking distance [6MWD]) and health-related quality of life (HRQL; SF36).

140 in objective of this study was to assess the health related quality of life (HRQoL) in children with

141 ived PRO symptoms, coupled with standardized Health Related Quality of Life (HRQOL) measures.

142 The association of smoking with angina and health-related quality of life (HRQOL) after AMI is uncl

143 Limited data exist on health-related quality of life (HRQoL) after intracerebr

144 BACKGROUND AND Limited data exist on health-related quality of life (HRQoL) after intracerebr

145 demographic factors influence the changes of health-related quality of life (HRQOL) among asthmatic c

146 s of this study were to assess morbidity and health-related quality of life (HrQoL) amongst former ru

147 Health-related quality of life (HRQol) and depression im

148 Purpose To examine changes in health-related quality of life (HRQoL) and its predictor

149 Measures of health-related quality of life (HRQOL) and other patient

150 Data concerning impact on health-related quality of life (HRQoL) and prognosticati

151 pazopanib or sunitinib and the influence of health-related quality of life (HRQoL) and safety factor

152 , and disease activity, as well as impact on health-related quality of life (HRQoL) and work among pa

153 HIV, but the effects of chronic infection on health-related quality of life (HRQoL) are unclear.

154 We aimed to compare health-related quality of life (HRQoL) between treatment

155 Missing health-related quality of life (HRQOL) data in longitudi

156 informed consent, demographics, clinical and health-related quality of life (HRQOL) data were collect

157 Purpose To compare pre-agreed health-related quality of life (HRQOL) domains in patien

158 ssess the adequacy of methods used to report health-related quality of life (HRQOL) from 49 eligible

159 Low health-related quality of life (HRQOL) has been associat

160 Negative effects of obesity on health-related quality of life (HRQoL) have been reporte

161 currently no specific instrument to measure health-related quality of life (HRQoL) impairment in pat

162 helium was associated with substantially low health-related quality of life (HRQoL) in adult Latinos

163 etin-stimulating agents (ESAs) for improving health-related quality of life (HRQOL) in anemia of chro

164 Obesity impairs cognition and health-related quality of life (HRQOL) in older adults;

165 ociated with fewer exacerbations or improved health-related quality of life (HRQOL) in patients with

166 By the increasing emphasis on health-related quality of life (HRQoL) in patients with

167 Purpose To determine if utility measures of health-related quality of life (HRQOL) in pediatric smal

168 Improving health-related quality of life (HRQoL) is an important t

169 ompression (MESCC), the impact of surgery on health-related quality of life (HRQoL) is not well estab

170 Health-related quality of life (HRQoL) measurement has b

171 tiva (HS) places a significant burden on the health-related quality of life (HRQOL) of patients, many

172 patients undergoing TA-TAVR derived similar health-related quality of life (HRQoL) outcomes when com

173 lief and postdischarge clinical outcomes and health-related quality of life (HRQOL) remains uncertain

174 Whether baseline health-related quality of life (hrQoL) resulted in a het

175 We now report the health-related quality of life (HRQOL) secondary endpoin

176 Health-related quality of life (HRQOL) usually improved

177 Pruritus and health-related quality of life (HRQoL) were assessed wit

178 Depression Scale depression, education, and health-related quality of life (HRQOL) were measured.

179 ere, we present the effects of treatments on health-related quality of life (HRQoL), an exploratory e

180 This study aimed to (1) assess the PROs (health-related quality of life (HRQoL), mental health an

181 eport the results of the secondary endpoint, health-related quality of life (HRQoL), of this trial.

182 We report the effect of enzalutamide on health-related quality of life (HRQoL), pain, and skelet

183 lthough adult insomnia is linked to worsened health-related quality of life (HRQOL), there is insuffi

184 udies have evaluated their health status and health-related quality of life (HRQoL).

185 allenges and can negatively affect patients' health-related quality of life (HRQoL).

186 ut how these populations compare in terms of health-related quality of life (HRQoL).

187 sinophilic asthma by examining its effect on health-related quality of life (HRQOL).

188 e with emotional well-being, depression, and health-related quality of life (HRQoL).

189 phasizing the importance of maintaining good health-related quality of life (HRQOL).

190 fluoropyrimidines has not shown benefits in health-related quality of life (HRQoL).

191 me to first cytotoxic therapy, toxicity, and health-related quality of life (HRQOL).

192 e shown that body weight is a determinant of health-related quality of life (HRQoL).

193 asures of pain control, and patient-reported health-related quality of life (HRQoL).

194 change in exercise capacity (VO(2peak)) and health-related quality of life (HRQOL).

195 ponse and duration of response), safety, and health-related quality of life (HRQoL).

196 een self-management of chronic back pain and health-related quality of life (HRQoL); (2) to examine t

197 t effect on cognitive, neuropsychiatric, and health-related quality-of-life (HRQoL) outcome measures.

198 This article reports the health-related quality-of-life (HRQOL) outcomes of this

199 e objectives of this article were to present health-related quality-of-life (HRQoL) results and a cos

200 Here, we report health-related quality-of-life (HRQOL) results.

201 ned virological response (SVR), safety data, health-related quality-of-life (HRQOL), and virological

202 treatment, comorbidity, physical and mental health-related quality of life [HRQoL]) and social parti

203 ction who had complete clinical, laboratory, health-related quality of life, imaging, and exercise te

204 ght be valid and reliable measures to assess health related quality of life in SLE patients and repre

205 f studies (14 of 20) showed higher levels of health-related quality of life in 1 or more domains foll

206 with comprehensive prospective assessment of health-related quality of life in a patient population c

207 ere associated with significant decreases in health-related quality of life in both the year of the e

208 from the KINDLR (Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescen

209 c peptide, the 6-min walk test distance, and health-related quality of life in heart failure.

210 veloped and validated for the measurement of health-related quality of life in patients with food all

211 provements are needed to optimise the use of health-related quality of life in randomised controlled

212 nce for increased levels of pain and reduced health-related quality of life in survivors of critical

213 an increasing focus on functional status and health-related quality of life in survivorship.

214 ain-related disability, and reduced physical health-related quality of life in the SF-36.

215 Affective symptoms influence health status (health-related quality of life) in functional neurologic

216 reduced post-stroke disability and improved health-related quality of life, indicating sustained ben

217 s associated with lower quality of life on a health-related quality-of-life instrument and the vision

218 Health-related quality of life is substantially lower fo

219 value or cause increased distress and lower health-related quality of life is unknown.

220 l Assessment), anxiety (STAI questionnaire), Health-Related Quality of Life (LDQoL 1.0 questionnaire)

221 in age- and sex-specific BMI z score, child health-related quality of life measured by the Pediatric

222 pecified secondary outcome measures included health-related quality of life measured with the EuroQol

223 er Disease Questionnaire (CLDQ), a validated health-related quality of life measurement.

224 n beyond 12 months or in in other domains of health-related quality-of-life measures.

225 ated quality of life was unaffected, but the health-related quality-of-life mental health domain incr

226 eview we assess the adequacy of reporting of health-related quality-of-life methods in randomised con

227 ptom Status Questionnaire-Heart Failure) and health-related quality of life (Minnesota Living with He

228 ng for COPD in asymptomatic persons improves health-related quality of life, morbidity, or mortality.

229 n = 16; 13%), visual acuity (n = 4; 3%), and health-related quality of life (n = 1; 1%)-were less fre

230 of bevacizumab to lomustine affected neither health-related quality of life nor neurocognitive functi

231 The health-related quality of life of 100 subjects with cult

232 termining how intermittent exotropia affects health-related quality of life of children with intermit

233 th opportunities to enhance the survival and health-related quality of life of individuals with this

234 dinal study is to verify changes in the oral health-related quality of life of patients 180 days afte

235 led trials of this disease are measuring the health-related quality of life of these patients.

236 subjective oral health outcomes (e.g., oral health-related quality of life [OHQoL]).

237 f non-surgical periodontal treatment on oral health-related quality of life (OHRQL).

238 ions related to ongoing research on the oral health-related quality of life (OHRQoL) in children with

239 ciation between periodontal disease and oral health-related quality of life (OHRQoL) in individuals w

240 f enamel fluorosis and dental caries on oral health-related quality of life (OHRQoL) in North Carolin

241 anced flap (CAF) on CDH, esthetics, and oral health-related quality of life (OHRQoL) of patients with

242 Since the start of the 21(st) century, oral health-related quality of life (OHRQoL) received increas

243 tion between gingival bleeding (GB) and oral health-related quality of life (OHRQoL).

244 Frail patients described lower health-related quality of life on both physical componen

245 , family or caregiver anxiety or depression, health-related quality of life or costs.

246 No differences in health-related quality of life or disease-specific survi

247 arch purposes such as determining changes in health-related quality of life or symptoms after an inte

248 ion support program did not impact patients' health-related quality-of-life or the likelihood that th

249 s in any other secondary outcomes, including health-related quality of life, or in rates of serious a

250 Safety, toxicity, and patient-reported health-related quality-of-life outcomes were assessed in

251 decisions, which in turn affect survival and health-related quality-of-life outcomes.

252 Trends for improvement in asthma control and health-related quality of life over the 48-week treatmen

253 linical features, psychological factors, and health-related quality of life (QoL), before and after d

254 Vitiligo has a major impact on health-related quality of life (QOL).

255 ailure (HF), a reality that can lead to poor health-related quality of life (QoL).

256 and used them for searching the literature: health-related quality of life/quality of life/HRQoL/QoL

257 Commonly used vision-targeted health-related quality of life questionnaires almost exc

258 3, and their parents from each of the 4 IXTQ health-related quality-of-life questionnaires (child 5 t

259 , auto-CPAP titration (for CPAP indication), health-related quality-of-life questionnaires, 24-hour b

260 pecific and overall function, improvement in health-related quality of life, reduction in work disabi

261 according to a visual analog scale (VAS), a health-related quality of life score (Skindex-29), 20-MH

262 nd proton pump inhibitor (PPI) therapy, GERD-Health Related Quality of Life scores, esophageal acid e

263 greater improvement in walking distances and health-related quality-of-life scores compared with supe

264 tal functioning, psychological distress, and health-related quality of life (secondary outcomes) in b

265 pressive symptoms, psychological well-being, health-related quality of life, sense of control over li

266 Primary outcomes included health-related quality of life (SF-12) for carers and qu

267 gimens in terms of function, disability, and health-related quality of life should be an important tr

268 At this time, all outcomes (BODE, 6MWD, and health-related quality of life) showed clinically and st

269 earch Council grade, >/=2), poor respiratory health-related quality of life (St. George's Respiratory

270 odified Medical Research Council grade 0-4), health-related quality of life (St. George's Respiratory

271 5 years of disease; the regression slope for health-related quality-of-life state from EQ-5D was not

272 mobility, correlations with other domains of health-related quality of life, such as cognitive functi

273 ance, and the Medical Outcomes Short-Form 36 health-related quality of life survey.

274 significantly lower (worse functioning) and health-related quality of life symptom scores higher (wo

275 he follow-up of triage patients showed lower health-related quality of life than an age- and sex-matc

276 At follow-up, triage patients had lower health-related quality of life than an age- and sex-matc

277 y meaningful improvement in overall physical health-related quality of life than laminectomy alone.

278 tantial impairments in physical function and health-related quality of life that continue beyond 24 m

279 tantial impairments in physical function and health-related quality of life that persisted at 24 mont

280 To improve physical symptoms and health-related quality of life, the modifiable factors a

281 ic cholecystectomy (LC) concerning costs and health-related quality of life using data from an expert

282 ously assessed the modified Rankin Scale and health-related quality of life using web-based computer

283 red, along with generic and disease-specific health-related quality of life, using standard scoring s

284 n (Walking Impairment Questionnaire), better health-related quality of life (VascuQol and EQ-5D), and

285 Although overall reporting of health-related quality of life was acceptable, improveme

286 Health-related quality of life was assessed by means of

287 Health-related quality of life was assessed with the Eur

288 Health-related quality of life was evaluated with valida

289 Health-related quality of life was measured at baseline,

290 Health-related quality of life was measured by the EuroQ

291 Health-related quality of life was similar between group

292 Health-related quality of life was superior in the throm

293 tments produced improvements in dyspnoea and health-related quality of life; we noted no significant

294 Abdominal pain, symptom relief, and health-related quality of life were assessed on a weekly

295 sttraumatic stress disorder, depression, and health-related quality of life were assessed with valida

296 dex, 6-minute-walk test distance (6MWD), and health-related quality of life were compared at 12, 24,

297 Check Index scores, systemic biomarkers, and health-related quality of life were measured at 3 and 6

298 dex, sweat chloride, nutritional status, and health-related quality of life were observed after 24 we

299 ed with gastric bypass while improvements in health-related quality of life were similar.

300 ce-daily triple therapy on lung function and health-related quality of life with twice-daily ICS/LABA